Diabetes as a coronary artery disease risk equivalent: before a change of paradigm?

Abstract

Background

Current guidelines consider diabetes per se as a coronary artery disease (CAD) risk equivalent. We aimed at investigating the contribution of baseline coronary atherosclerosis to the risk of diabetic patients for future vascular events. Design Prospective cohort study.

Methods

Vascular events were recorded over 4 years in 750 consecutive patients undergoing coronary angiography for the evaluation of stable CAD.

Results

From our patients, 244 had neither type 2 diabetes (T2DM) nor significant CAD (i.e. coronary stenoses ≥ 50%) at the baseline angiography, 50 had T2DM but not significant CAD, 342 did not have T2DM but had significant CAD, and 114 had both T2DM and significant CAD. Nondiabetic patients without significant CAD had an event rate of 9.0%. The event rate was similar in T2DM patients without significant CAD (8.0%, P = 0.951), but higher in nondiabetic patients with significant CAD (24.9%, P < 0.001). Patients with T2DM and significant CAD had the highest event rate (43.0%). Importantly, T2DM patients without significant CAD had a significantly lower event rate than nondiabetic patients with significant CAD (P = 0.008).

Conclusion

T2DM per se is not a CAD risk equivalent. Moderate-risk diabetic patients without significant CAD and very high-risk diabetic patients with significant CAD add up to a grand total of high-risk diabetic patients, this is why diabetes seems to be a CAD risk equivalent in many epidemiological studies.

Keywords

cardiovascular risk coronary angiography coronary artery disease type 2 diabetes

Get full access to this article

View all access options for this article.

References

Haffner

Lehto

Ronnemaa

Pyorala

Laakso

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229–234.

2 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486–2497.

Whiteley

Padmanabhan

Hole

Isles

Should diabetes be considered a coronary heart disease risk equivalent? results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care 2005; 28:1588–1593.

4 Malmberg

Yusuf

Gerstein

Brown

Zhao

Hunt

, et al. Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 2000; 102:1014–1019.

5 Mukamal

Nesto

Cohen

Muller

Maclure

Sherwood

, et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24:1422–1427.

Natarajan

Liao

Sinha

Cao

McGee

Lipsitz

SR.

Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 2005; 165:430–435.

Juutilainen

Lehto

Ronnemaa

Pyorala

Laakso

Type 2 diabetes as a coronary heart disease equivalent: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005; 28:2901–2907.

Simons

Diabetes and coronary heart disease. N Engl J Med 1998; 339:1714–1715.

9 Lotufo

Gaziano

Chae

Ajani

Moreno-John

Buring

, et al. Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 2001; 161:242–247.

10.

Evans

Wang

Morris

AD.

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002; 324:939–942.

11.

Lee

Folsom

Pankow

Brancati

FL.

Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004; 109:855–860.

12.

Vaccaro

Eberly

Neaton

Yang

Riccardi

Stamler

Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the multiple risk factor intervention trial. Arch Intern Med 2004; 164:1438–1443.

13.

Cho

Rimm

Stampfer

Willett

FB.

The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002; 40:954–960.

14.

14 Becker

Bos

de Vegt

Kostense

Dekker

Nijpels

, et al. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J 2003; 24:1406–1413.

15.

Jousilahti

Qiao

Peltonen

Katoh

Tuomilehto

The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J Am Coll Cardiol 2005; 45:1413–1418.

16.

Buyken

von Eckardstein

Schulte

Cullen

Assmann

Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study. Eur J Cardiovasc Prev Rehabil 2007; 14:230–236.

17.

Drexel

Aczel

Marte

Benzer

Langer

Moll

Drexel

Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol? Diabetes Care 2005; 28:101–107.

18.

18 Drexel

Amann

Beran

Rentsch

Candinas

Muntwyler

, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994; 90:2230–2235.

19.

Bulugahapitiya

Siyambalapitiya

Sithole

Idris

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009; 26:142–148.

20.

20 Hu

Stampfer

Solomon

Liu

Willett

Speizer

, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001; 161:1717–1723.

21.

21 Buse

Ginsberg

Bakris

Clark

Costa

Eckel

, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007; 115:114–126.

22.

22 Ogawa

Nakayama

Morimoto

Uemura

Kanauchi

Doi

, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008; 300:2134–2141.

23.

Saely

Aczel

Marte

Langer

Drexel

Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia 2004; 47:145–146.

24.

Anselmino

Malmberg

Ohrvik

Ryden

Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008; 15:216–223.

25.

Kotseva

Wood

De Backer

De Bacquer

Pyorala

Keil

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16:121–137.

26.

26 Jacobs-van der Bruggen

Engelfriet

Hoogenveen

van Baal

Struijs

Verschuren

, et al. Lipid-lowering treatment for all could substantially reduce the burden of macrovascular complications of diabetes patients in the Netherlands. Eur J Cardiovasc Prev Rehabil 2008; 15:521–525.

27.

27 Langer

Wiemer

Peterschroder

Franzke

Mellwig

van Buuren

, et al. Stratification for noninvasive coronary angiography: patient preselection considering atypical angina pectoris, conventional cardiovascular risk assessment, and calcium scoring. Eur J Cardiovasc Prev Rehabil 2009; 16:201–209.